Tirzepatide, a cutting-edge medication initially approved for the treatment of type 2 diabetes, has shown remarkable potential in facilitating significant weight loss. This dual GIP and GLP-1 receptor ...
The use of weight-loss drugs could be "monumental" in tackling the problem of short- and long-term economic inactivity caused by obesity-related health conditions. Streeting announced a ...